title: Biomarkers: potential uses and limitations.
abstract: Biomarkers provide a dynamic and powerful approach to understanding the spectrum of neurological disease with applications in observational and analytic epidemiology, randomized clinical trials, screening and diagnosis and prognosis. Defined as alterations in the constituents of tissues or body fluids, these markers offer the means for homogeneous classification of a disease and risk factors, and the can extend our base information about the underlying pathogenesis of disease. Biomarkers can also reflect the entire spectrum of disease from the earliest manifestations to the terminal stages. This brief review describes the major uses of biomarkers in clinical investigation. Careful assessment of the validity of biomarkers is required with respect to the stage of disease. Causes of variability in the measurement of biomarkers range from the individual to the laboratory. Issues that affect the analysis of biomarkers are discussed along with recommendations on how to deal with bias and confounding.
authors.affiliation: Gertrude H. Sergievsky Center and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. rpm2@columbia.edu
authors.forename: Richard
authors.initials: R
authors.lastname: Mayeux
mesh_terms: D015415:Biomarkers; D006801:Humans; D008403:Mass Screening; D009422:Nervous System Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000378:metabolism*; D011379:Prognosis; D012307:Risk Factors
chemical_list: D015415:Biomarkers
references.citation: J Mol Med (Berl). 1996 Feb;74(2):71-84
references.pmid: 8820402
references.citation: Annu Rev Neurosci. 2003;26:81-104
references.pmid: 12574495
references.citation: Stat Med. 1989 Oct;8(10):1277-90
references.pmid: 2814075
references.citation: Int J Neuropsychopharmacol. 2001 Mar;4(1):93-102
references.pmid: 11343634
references.citation: N Engl J Med. 1998 Feb 19;338(8):506-11
references.pmid: 9468467
references.citation: Acta Psychiatr Scand. 2002 Jan;105(1):3-13
references.pmid: 12086223
references.citation: Expert Rev Mol Diagn. 2003 Sep;3(5):525-9
references.pmid: 14510173
references.citation: Ann Clin Biochem. 2003 Jan;40(Pt 1):25-40
references.pmid: 12542908
references.citation: J Neurol Sci. 2001 Mar 1;184(2):101-22
references.pmid: 11239944
references.citation: Clin Geriatr Med. 2001 May;17(2):393-410
references.pmid: 11375142
references.citation: Biostatistics. 2000 Jun;1(2):123-40
references.pmid: 12933515
references.citation: Carcinogenesis. 2000 Mar;21(3):517-24
references.pmid: 10688872